Identification of risk factors for postoperative persistent hypertension in patients with pheochromocytoma

被引:0
作者
Lu, Shiyang [1 ]
Wang, Chao [1 ]
Tian, Xueyan [1 ]
Zhang, Tong [1 ]
机构
[1] China Med Univ, Dept Urol, Shengjing Hosp, 36 Sanhao St, Shenyang 110004, Liaoning, Peoples R China
关键词
adrenalectomy; blood pressure; hypertension; pheochromocytoma; risk factors; BLOOD-PRESSURE; MORBIDITY; ADRENALECTOMY; MATRIX;
D O I
10.1002/jso.27764
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Surgical resection is the primary management for pheochromocytoma. However, some patients with pheochromocytoma still suffer from hypertension after successful adrenalectomy. The risk factors for postoperative persistent hypertension remain unclear. Thus the aim of the present study was to identify the risk factors of postoperative persistent hypertension in patients with pheochromocytoma concomitant with hypertension. Methods: We retrospectively analyzed 259 patients with pheochromocytoma who underwent adrenalectomy in our hospital between January 1, 2007, and December 31, 2018. Patients' demographics, comorbidities, and perioperative data were recorded. The odds ratio (OR) and 95% confidence interval were measured through binary logistic regression. The cutoff values and the area under the curve (AUC) for continuous risk factors of persistent hypertension after adrenalectomy were calculated through receiver operating characteristic curve analysis. Results: Of the 259 patients, 40.9% (106/259) patients experienced postoperative persistent hypertension. Three independent risk factors of persistent hypertension in patients with pheochromocytoma after adrenalectomy were found to be older age (OR = 1.16, p = 0.037), longer duration of hypertension (OR = 3.10, p = 0.01), and concomitance with cardiovascular events (yes vs. no, OR = 17.17, p = 0.049). The cutoff value of age and duration of hypertension was 66 years (AUC = 0.741, p < 0.0001) and 27 months (AUC = 0.991, p < 0.0001), respectively. Conclusions: Collectively, older age, a longer duration of hypertension, and concomitance with cardiovascular events were independent risk factors of persistent hypertension in patients with pheochromocytoma after adrenalectomy. These findings may help in improving perioperative management and follow-up strategies.
引用
收藏
页码:380 / 385
页数:6
相关论文
共 24 条
  • [1] 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
    Afridi, I
    Canny, J
    Yao, CH
    Christensen, B
    Cooper, RS
    Kadiri, S
    Hill, S
    Kaplan, N
    Kuschnir, E
    Lexchin, J
    Mendis, S
    Poulter, N
    Psaty, BM
    Rahn, KH
    Sheps, SG
    Whitworth, J
    Yach, D
    Bengoa, R
    Ramsay, L
    Kaplan, N
    Mendis, S
    Poulter, N
    Whitworth, J
    [J]. JOURNAL OF HYPERTENSION, 2003, 21 (11) : 1983 - 1992
  • [2] Development and validation of a predictive model for predicting cardiovascular morbidity in patients after pheochromocytoma surgery
    Bai, Song
    Wu, Bin
    Yao, Zichuan
    Zhu, Xianqing
    Jiang, Yunzhong
    Bu, Renge
    [J]. CLINICAL ENDOCRINOLOGY, 2019, 91 (04) : 490 - 497
  • [3] Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients
    Brunaud, Laurent
    Phi-Linh Nguyen-Thi
    Mirallie, Eric
    Raffaelli, Marco
    Vriens, Menno
    Theveniaud, Pierre-Etienne
    Boutami, Myriam
    Finnerty, Brendan M.
    Vorselaars, Wessel M. C. M.
    Rinkes, Inne Borel
    Bellantone, Rocco
    Lombardi, Celestino
    Fahey, Thomas, III
    Zarnegar, Rasa
    Bresler, Laurent
    [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2016, 30 (03): : 1051 - 1059
  • [4] Association Between Circulating Endostatin, Hypertension Duration, and Hypertensive Target-Organ Damage
    Carlsson, Axel C.
    Ruge, Toralph
    Sundstrom, Johan
    Ingelsson, Erik
    Larsson, Anders
    Lind, Lars
    Arnlov, Johan
    [J]. HYPERTENSION, 2013, 62 (06) : 1146 - 1151
  • [5] Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?
    Collier, Patrick
    Watson, Chris J.
    Voon, Victor
    Phelan, Dermot
    Jan, Aftab
    Mak, George
    Martos, Ramon
    Baugh, John A.
    Ledwidge, Mark T.
    McDonald, Kenneth M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (10) : 1087 - 1095
  • [6] Pheochromocytoma and functional paraganglioma syndrome: No longer the 10% tumor
    Elder, EE
    Elder, G
    Larsson, C
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2005, 89 (03) : 193 - 201
  • [7] Endothelial cell senescence in aging-related vascular dysfunction
    Jia, Guanghong
    Aroor, Annayya R.
    Jia, Cassie
    Sowers, James R.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (07): : 1802 - 1809
  • [8] Perioperative Risk Factors, Morbidity, and Outcome of 145 Patients during Phaeochromocytoma Resection
    Kazic, M. R.
    Zivaljevic, V. R.
    Milan, Z. B.
    Paunovic, I. R.
    [J]. ACTA CHIRURGICA BELGICA, 2011, 111 (04) : 223 - 227
  • [9] Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma
    Kopetschke, Robert
    Slisko, Mario
    Kilisli, Aylin
    Tuschy, Ulrich
    Wallaschofski, Henri
    Fassnacht, Martin
    Ventz, Manfred
    Beuschlein, Felix
    Reincke, Martin
    Reisch, Nicole
    Quinkler, Marcus
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 161 (02) : 355 - 361
  • [10] Lipomatous tumours in adrenal gland: WHO updates and clinical implications
    Lam, Alfred King-yin
    [J]. ENDOCRINE-RELATED CANCER, 2017, 24 (03) : R65 - R79